3Mehran R,Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention : development and initial validation [ J]. J Am Coll Cardiol,2004 ,44 (7) : 1393-1399.
4Briguori C, Airoldi F, Moriei N, et al. New pharmacological protocols to prevent or reduce contrast media nephropathy [J]. Minerva Cardioangiol,2005,53 ( 1 ) :49-58.
5Habeb M, AgacMT, Aliyev F, et al. Contrast media-induced nephropathy:clinical burden and current attempts for prevention [ J]. Anadolu Kardiyol Derg,2005,5 (2) : 124-129.
6Morcos SK. Prevention of contrast media nephrotoxieity-the story so far [J]. Clin Radiol,2004,59(5) :381-389.
7Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study [J]. Arch Intern Med, 1990,150 (6) : 1237-1242.
8Chello M, Goffredo C, Patti G, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery [ J]. Eur J Cardiothorac Surg,2005,28(6) :805-810.
9Attallah N, Yassine L, Musial J, et al. The potential role of statins in contrast nephropathy [ J ]. Clin Nephrol,2004,62 (4) :273-278.
